Author

O. Rogers

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. K. Aragaki· 1 shared B. A. Johnson· 1 shared D. Dordai· 1 shared D. J. McConkey· 1 shared D. M. Williams· 1 shared J. Mountain· 1 shared L. Chia· 1 shared L. Luo· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. K. Aragaki

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The indoleamine 2,3 dioxygenase pathway drives intratumoral B cell maintenance.

B. A. Johnson, A. K. Aragaki, D. M. Williams, O. Rogers, J. Mountain, L. Luo, W. Zhang, L. Xian, M. Feng, L. Chia, D. Dordai, N. M. Hahn, S. Desiderio, T. S. Johnson, D. J. McConkey, L. M. S. Resar

This study shows that inhibiting the IDO1 pathway reduces tumor-infiltrating B cells in melanoma models, suggesting potential therapeutic strategies for solid tumors.

bioRxiv · Aug 25, 2021 · PreprintImmunology